Related Experiment Video
Updated: May 2, 2026

The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
Published on: May 16, 2016
Collaborative research in myositis-related disorders: MIHRA, a global shared community model
Lesley Ann Saketkoo1, Julie J Paik2, Helene Alexanderson3
1New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, Louisiana State University and Tulane University Schools of Medicine, New Orleans, LA, USA. lsaketk@tulane.edu.
The Myositis International Health and Research Collaborative Alliance (MIHRA) is a new non-profit accelerating global research and education for Idiopathic Inflammatory Myopathies (IIM). MIHRA aims to unite experts and patients to advance rare disease advocacy and find a cure.
Area of Science:
- Rheumatology and Immunology
- Rare Diseases Research
- Clinical Trial Acceleration
Background:
- Idiopathic Inflammatory Myopathies (IIM) represent a group of rare autoimmune disorders requiring specialized research and care.
- Existing challenges in rare disease research include clinical trial readiness, global collaboration, and professional/patient education.
- A unified global approach is needed to address the complexities of IIM research and patient support.
Purpose of the Study:
- To introduce the Myositis International Health and Research Collaborative Alliance (MIHRA) as a dedicated non-profit research organization.
- To outline MIHRA's mission to accelerate international clinical trial readiness, education, and advocacy for IIM-related disorders.
- To detail MIHRA's operational framework for fostering global, multi-disciplinary collaboration in IIM research.
Main Methods:
- Establishing a non-profit charitable research organization (MIHRA) with a global, multi-disciplinary focus.
- Developing infrastructure and programming to address rare disease research challenges.
- Creating a platform for investigator-initiated projects, consensus guidelines, and career development.
- Streamlining ethics and data-sharing policies to facilitate collaborative research.
Main Results:
- MIHRA has been formed as a purpose-built organization uniting healthcare professionals, researchers, and patient advisors globally.
- MIHRA provides a resourced platform for collaborative efforts in IIM research, assessment, and treatment.
- The organization is designed to overcome rare disease research barriers through global expansion, inclusivity, and resource utilization.
Conclusions:
- MIHRA aims to sustain, accelerate, and grow global collaborative research in myositis-related disorders.
- The organization's operational cores, mission, and vision are geared towards transformative rare disease research models.
- MIHRA signifies a commitment to advancing the understanding and treatment of IIM through international cooperation and community engagement.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology

